HHLR Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

HHLR Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Hold	5,980,568	–	–	1.4%	13
2026 Q1	$14.7M	Hold	5,980,568	–	–	0.88%	12
2025 Q4	$23.8M	Hold	5,980,568	–	–	0.77%	11
2025 Q3	$22.6M	Hold	5,980,568	–	–	0.55%	16
2025 Q2	$14.5M	Hold	5,980,568	–	–	0.47%	17
2025 Q1	$4.93M	Hold	5,980,568	–	–	0.14%	27
2024 Q4	$5.08M	Sell	5,980,568 -928,652	-13%	-$1.03M	0.18%	23
2024 Q3	$8.57M	Hold	6,909,220	–	–	0.19%	23
2024 Q2	$11.5M	Hold	6,909,220	–	–	0.28%	29
2024 Q1	$12.9M	Hold	6,909,220	–	–	0.28%	27
2023 Q4	$13.1M	Hold	6,909,220	–	–	0.26%	27
2023 Q3	$9.12M	Hold	6,909,220	–	–	0.2%	36
2023 Q2	$20.7M	Sell	6,909,220 -45,222	-0.7%	-$145K	0.44%	25
2023 Q1	$24.1M	Sell	6,954,442 -228,408	-3%	-$1.11M	0.43%	28
2022 Q4	$30M	Hold	7,182,850	–	–	0.63%	26
2022 Q3	$28.8M	Hold	7,182,850	–	–	0.76%	26
2022 Q2	$81.2M	Hold	7,182,850	–	–	1.74%	15
2022 Q1	$117M	Hold	7,182,850	–	–	2.44%	11
2021 Q4	$340M	Hold	7,182,850	–	–	5.26%	5
2021 Q3	$521M	Buy	7,182,850 +566,680	+9%	+$41M	6.81%	3
2021 Q2	$555M	Hold	6,616,170	–	–	5.72%	4
2021 Q1	$321M	Buy	6,616,170 +5,119,630	+342%	+$278M	3.17%	10
2020 Q4	$70.6M	Hold	1,496,540	–	–	0.56%	28
2020 Q3	$70.4M	Buy	+1,496,540	New	+$49.3M	0.53%	27

Other funds holding NBP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HHLR Advisors's NBP Position: Q2 2026 in Review

HHLR Advisors held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 5,980,568 shares worth $11.7M. The position accounts for 1.4% of the portfolio, ranked #13.

HHLR Advisors first reported a position in NBP in Q3 2020 and has held it in 24 quarters since. The position peaked at $555M in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

HHLR Advisors held 5,980,568 shares of NovaBridge Biosciences American Depositary Shares worth $11.7M as of Q2 2026.
HHLR Advisors left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up 1.4% of HHLR Advisors's portfolio in Q2 2026, its #13 holding.
HHLR Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 24 quarters since.
HHLR Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $555M in Q2 2021.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.